Watch our complimentary on-demand webinar titled “Sustained gut dysbiosis in murine polymicrobial sepsis: Identification of longitudinal changes in the gut microbiome using strain-level resolution rRNA amplicon sequencing”.
Shoreline Biome will present its high-resolution gut microbiome research at the upcoming Microbiome Innovation Summit at The Jackson Laboratory. Co-presenters will include the University of Connecticut Health Schools of Medicine & Dental Medicine and The Jackson Laboratory Center for Genomic Medicine.
Shoreline Biome kits generate the long amplicon required to discriminate microbial strains on PacBio Sequel systems FARMINGTON, Conn.—Shoreline Biome, a microbiome research company based here that develops tools for characterizing microbiome populations down to the strain level, will be an attendee and sponsor of the 2019 PacBio Users Group Meeting North America (UGM). The UGM […]
The DNA Genotek OMNIgene•GUT collection system is compatible with the Shoreline Complete microbiome sample preparation kit allowing for convenient stabilization of fecal microbial samples followed by high-throughput lysis and amplification for microbiome NGS profiling. Read more.
Shoreline Biome’s proprietary technology combines a series of innovations; lysis, DNA prep, and PCR to significantly reduce hands-on time and time to result while improving coverage and representation of bacteria in microbiome samples.
FOR IMMEDIATE RELEASE Expanded leadership team brings experience from pharmaceutical and biotechnology industries FARMINGTON, Conn.— Shoreline Biome, a microbiome research company based here that develops tools for characterizing microbiome populations down to the strain level, has hired Bill McKenzie as its CEO and Karen Woodward as its VP of Business Development. These two new hires […]
This Tech Note describes how we use the StrainID kit to compare representation of different microbial strains between Shoreline Biome rapid lysis and commercially available DNA preparation methods.
As the understanding of the impact of an individual’s microbiome on their overall health, disease severity, and / or response to medications grows, the importance of high quality and standardized collection and processing techniques becomes ever more important.
Shoreline Biome, a microbiome research company based here that develops tools for characterizing microbiome populations down to the strain level, has announced partnerships with six international distributors.